The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

Mar. 18, 2022
Applicant:

Gholam A. Peyman, Sun City, AZ (US);

Inventor:

Gholam A. Peyman, Sun City, AZ (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/215 (2006.01); A61K 31/155 (2006.01); A61K 31/422 (2006.01); A61K 31/506 (2006.01); A61K 39/39 (2006.01); A61K 39/395 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 35/13 (2015.01); A61K 35/66 (2015.01); A61K 35/74 (2015.01); A61K 35/76 (2015.01); A61K 36/06 (2006.01); A61K 39/00 (2006.01); C12N 1/00 (2006.01); C12N 1/02 (2006.01);
U.S. Cl.
CPC ...
A61K 39/215 (2013.01); A61K 31/155 (2013.01); A61K 31/422 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 35/13 (2013.01); A61K 35/66 (2013.01); A61K 35/74 (2013.01); A61K 35/76 (2013.01); A61K 36/06 (2013.01); A61K 39/00 (2013.01); A61K 39/39 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C12N 1/00 (2013.01); C12N 1/02 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55511 (2013.01); C12N 2501/999 (2013.01);
Abstract

A therapeutic vaccination method includes growing and harvesting viruses, bacteria, fungi, parasites, or tumor cells on a cell culture or other appropriate medium; killing the viruses, bacteria, fungi, parasites, or tumor cells in the cell culture or other appropriate medium with a dose of methylene blue; separating the dead viruses, bacteria, fungi, parasites, or tumor cells from a remainder of the cell culture or other appropriate medium using a filter and/or centrifuge; adding antivirals, antibacterials, antifungals, antiparasitics, and/or anti-neoplastic medications at non-toxic therapeutic concentrations to the dead viruses, bacteria, fungi, parasites, or tumor cells so as to form a therapeutic vaccine; and administering the therapeutic vaccine to a patient in need thereof to simultaneously produces a therapeutic response and a humoral and cellular immune response in the body of the patient without resulting in deleterious side effects to the patient.


Find Patent Forward Citations

Loading…